TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicenter Prospective Clinical Trial to Evaluate Efficacy of Respiratory Rehabilitation Personalized Mobile Services for Respiratory Diseases
Brief Summary: This trial is multicenter prospective study to evaluate clinical efficacy of respiratory rehabilitation personalized mobile services for respiratory disease.


Options:
A: Arm Label: Group A, Telerehabilitation; Type: EXPERIMENTAL; Interventions: Other: Telerehabilitation | Arm Label: Group B, Hospital based Rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Other: Hospital based Rehabilitation | Arm Label: Group C, Usual care Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Telerehabilitation; Assigned to Arm(s): Group A, Telerehabilitation | Intervention Type: OTHER; Name: Hospital based Rehabilitation; Assigned to Arm(s): Group B, Hospital based Rehabilitation
B: Arm Label: HappyAir Group; Type: EXPERIMENTAL; Interventions: Other: Pulmonary Care Web-Based App (HappyAir App) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Pulmonary Care Web-Based App (HappyAir App); Assigned to Arm(s): HappyAir Group
C: Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supervised COPD Rehabilitation (control group) | Arm Label: Online COPD rehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Online COPD rehabilitation (experimental) | Intervention Type: BEHAVIORAL; Name: Supervised COPD Rehabilitation (control group); Assigned to Arm(s): Control group | Intervention Type: BEHAVIORAL; Name: Online COPD rehabilitation (experimental); Assigned to Arm(s): Online COPD rehabilitation
D: Arm Label: Fixed respiratory rehabilitation program(A); Type: EXPERIMENTAL; Interventions: Other: Fixed respiratory rehabilitation | Arm Label: Mixed respiratory rehabilitation program(B); Type: EXPERIMENTAL; Interventions: Other: Fixed respiratory rehabilitation, Other: Responsive respiratory rehabilitation | Arm Label: Control(C); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Fixed respiratory rehabilitation; Assigned to Arm(s): Fixed respiratory rehabilitation program(A), Mixed respiratory rehabilitation program(B) | Intervention Type: OTHER; Name: Responsive respiratory rehabilitation; Assigned to Arm(s): Mixed respiratory rehabilitation program(B)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicenter Prospective Clinical Trial to Evaluate Efficacy of Respiratory Rehabilitation Personalized Mobile Services for Respiratory Diseases
Brief Summary: This trial is multicenter prospective study to evaluate clinical efficacy of respiratory rehabilitation personalized mobile services for respiratory disease.


Options:
A: Arm Label: Fixed respiratory rehabilitation program(A); Type: EXPERIMENTAL; Interventions: Other: Fixed respiratory rehabilitation | Arm Label: Mixed respiratory rehabilitation program(B); Type: EXPERIMENTAL; Interventions: Other: Fixed respiratory rehabilitation, Other: Responsive respiratory rehabilitation | Arm Label: Control(C); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Fixed respiratory rehabilitation; Assigned to Arm(s): Fixed respiratory rehabilitation program(A), Mixed respiratory rehabilitation program(B) | Intervention Type: OTHER; Name: Responsive respiratory rehabilitation; Assigned to Arm(s): Mixed respiratory rehabilitation program(B)
B: Arm Label: Pulmonary Telerehabilitation Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Pulmonary Telerehabilitation | Arm Label: Usual Care Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pulmonary Telerehabilitation; Assigned to Arm(s): Pulmonary Telerehabilitation Intervention Group
C: Arm Label: CST; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone-based Enhanced Coping Skills Training (CST) | Arm Label: UMC; Type: OTHER; Interventions: Other: Usual Medical Care and COPD education and symptom monitoring (UMC) | Intervention Type: BEHAVIORAL; Name: Telephone-based Enhanced Coping Skills Training (CST); Assigned to Arm(s): CST | Intervention Type: OTHER; Name: Usual Medical Care and COPD education and symptom monitoring (UMC); Assigned to Arm(s): UMC
D: Arm Label: Face to Face Pulmonary Rehabilitaton; Type: OTHER; Interventions: Behavioral: Face to Face Pulmonary Rehabilitaton | Arm Label: Online Pulmonary Rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Online Pulmonary Rehab | Intervention Type: BEHAVIORAL; Name: Face to Face Pulmonary Rehabilitaton; Assigned to Arm(s): Face to Face Pulmonary Rehabilitaton | Intervention Type: BEHAVIORAL; Name: Online Pulmonary Rehab; Assigned to Arm(s): Online Pulmonary Rehabilitation

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Seroma Following Inguinal Lymph Node Dissection With Prophylactic Incisional Negative Pressure Wound Therapy
Brief Summary: Inguinal lymph node dissection (ILND) is indicated following metastatic malignant melanoma, and is associated with a high-complication rate, of which many begin with the formation of seroma and ends in complicated wound healing, reoperation, multiple outpatient visits and re-hospitalization. Prevention of seroma may therefore lead to a reduction of many of the preceding complications and improve patient quality-of-life. The aim of this study is to evaluate the efficacy and oncological safety of prophylactic negative pressure wound therapy following ILND in melanoma patients.


Options:
A: Arm Label: Dry Dressing; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Negative Pressure Wound Therapy; Type: EXPERIMENTAL; Interventions: Device: V.A.C. by K.C.I. | Intervention Type: DEVICE; Name: V.A.C. by K.C.I.; Assigned to Arm(s): Negative Pressure Wound Therapy
B: Arm Label: Vacuum assisted closure; Type: EXPERIMENTAL; Interventions: Procedure: vacuum assisted closure | Arm Label: Axillary dissection; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Axillary dissection | Intervention Type: PROCEDURE; Name: vacuum assisted closure; Assigned to Arm(s): Vacuum assisted closure | Intervention Type: PROCEDURE; Name: Axillary dissection; Assigned to Arm(s): Axillary dissection
C: Arm Label: Negative pressure wound therapy; Type: EXPERIMENTAL; Interventions: Device: Negative pressure wound therapy | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Micropore tape | Intervention Type: DEVICE; Name: Negative pressure wound therapy; Assigned to Arm(s): Negative pressure wound therapy | Intervention Type: OTHER; Name: Micropore tape; Assigned to Arm(s): Control
D: Arm Label: Negative Pressure Wound Therapy; Type: EXPERIMENTAL; Interventions: Device: Negative pressure wound therapy | Arm Label: Standard dressing; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Negative pressure wound therapy; Assigned to Arm(s): Negative Pressure Wound Therapy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Seroma Following Inguinal Lymph Node Dissection With Prophylactic Incisional Negative Pressure Wound Therapy
Brief Summary: Inguinal lymph node dissection (ILND) is indicated following metastatic malignant melanoma, and is associated with a high-complication rate, of which many begin with the formation of seroma and ends in complicated wound healing, reoperation, multiple outpatient visits and re-hospitalization. Prevention of seroma may therefore lead to a reduction of many of the preceding complications and improve patient quality-of-life. The aim of this study is to evaluate the efficacy and oncological safety of prophylactic negative pressure wound therapy following ILND in melanoma patients.


Options:
A: Arm Label: Closed Incision Wound vacuum (Prevena); Type: EXPERIMENTAL; Interventions: Device: Closed incision wound vacuum (Prevena) | Arm Label: Routine Wound Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Closed incision wound vacuum (Prevena); Assigned to Arm(s): Closed Incision Wound vacuum (Prevena)
B: Arm Label: Dry Dressing; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Negative Pressure Wound Therapy; Type: EXPERIMENTAL; Interventions: Device: V.A.C. by K.C.I. | Intervention Type: DEVICE; Name: V.A.C. by K.C.I.; Assigned to Arm(s): Negative Pressure Wound Therapy
C: Arm Label: Negative pressure wound therapy; Type: EXPERIMENTAL; Interventions: Device: Negative pressure wound therapy | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Micropore tape | Intervention Type: DEVICE; Name: Negative pressure wound therapy; Assigned to Arm(s): Negative pressure wound therapy | Intervention Type: OTHER; Name: Micropore tape; Assigned to Arm(s): Control
D: Arm Label: Current Standard; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard Tegaderm (3M Healthcare, St. Paul, MN) adhesive dressing | Arm Label: Negative Pressure Wound Therapy; Type: EXPERIMENTAL; Interventions: Device: Prevena (Negative Pressure Wound Therapy Device) | Intervention Type: DEVICE; Name: Prevena (Negative Pressure Wound Therapy Device); Assigned to Arm(s): Negative Pressure Wound Therapy | Intervention Type: DEVICE; Name: Standard Tegaderm (3M Healthcare, St. Paul, MN) adhesive dressing; Assigned to Arm(s): Current Standard

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Seroma Following Inguinal Lymph Node Dissection With Prophylactic Incisional Negative Pressure Wound Therapy
Brief Summary: Inguinal lymph node dissection (ILND) is indicated following metastatic malignant melanoma, and is associated with a high-complication rate, of which many begin with the formation of seroma and ends in complicated wound healing, reoperation, multiple outpatient visits and re-hospitalization. Prevention of seroma may therefore lead to a reduction of many of the preceding complications and improve patient quality-of-life. The aim of this study is to evaluate the efficacy and oncological safety of prophylactic negative pressure wound therapy following ILND in melanoma patients.


Options:
A: Arm Label: Negative pressure wound therapy; Type: EXPERIMENTAL; Interventions: Device: Negative pressure wound therapy | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Micropore tape | Intervention Type: DEVICE; Name: Negative pressure wound therapy; Assigned to Arm(s): Negative pressure wound therapy | Intervention Type: OTHER; Name: Micropore tape; Assigned to Arm(s): Control
B: Arm Label: patients with preventive PICO; Type: ACTIVE_COMPARATOR; Interventions: Device: PICO DRESSING | Arm Label: patients with preventive MEPORE; Type: PLACEBO_COMPARATOR; Interventions: Device: MEPORE dressing | Intervention Type: DEVICE; Name: PICO DRESSING; Assigned to Arm(s): patients with preventive PICO | Intervention Type: DEVICE; Name: MEPORE dressing; Assigned to Arm(s): patients with preventive MEPORE
C: Arm Label: Vacuum assisted closure; Type: EXPERIMENTAL; Interventions: Procedure: vacuum assisted closure | Arm Label: Axillary dissection; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Axillary dissection | Intervention Type: PROCEDURE; Name: vacuum assisted closure; Assigned to Arm(s): Vacuum assisted closure | Intervention Type: PROCEDURE; Name: Axillary dissection; Assigned to Arm(s): Axillary dissection
D: Arm Label: Simple dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Smith & Nephew PICO Negative wound pressure versus standard dresing, Device: PREVENA Negative pressure wound versus standard dressing | Arm Label: PICO Dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: PREVENA Negative pressure wound versus standard dressing | Arm Label: PREVENA Dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Smith & Nephew PICO Negative wound pressure versus standard dresing | Intervention Type: DEVICE; Name: Smith & Nephew PICO Negative wound pressure versus standard dresing; Assigned to Arm(s): PREVENA Dressing, Simple dressing | Intervention Type: DEVICE; Name: PREVENA Negative pressure wound versus standard dressing; Assigned to Arm(s): PICO Dressing, Simple dressing

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Role of Music in Improving Gait Abnormalities in Parkinson Disease
Brief Summary: Neurologic Music Therapy (NMT) sensorimotor techniques are increasingly used to improve spatio-temporal gait parameters and postural stability in the course of Parkinson's Disease and following stroke. Nonetheless, the neurophysiological underpinnings of NMT-mediated gait recovery is still poorly understood.

The aim of the study was to investigate the central mechanisms of connectivity related to the application of Rhythmic Auditory Stimulation (RAS) in PD gait rehabilitation. The investigators will enroll 30 patients with PD. They will be randomized into two groups: (A) gait training with Music; (B) conventional treadmill gait training. The experimental group will perform training by means of GT3 (Biodex), where the patient is able to walk (on a treadmill) following specific musical beets and rhythms. The control group will perform only gait treadmill training.

Subjects will attend 3 sessions a week for at least 4 weeks. Each session will last 45-min.


Options:
A: Arm Label: IPX066; Type: EXPERIMENTAL; Interventions: Drug: IPX066, Drug: IR CD-LD | Arm Label: IR CD-LD; Type: ACTIVE_COMPARATOR; Interventions: Drug: IPX066, Drug: IR CD-LD | Intervention Type: DRUG; Name: IPX066; Assigned to Arm(s): IPX066, IR CD-LD | Intervention Type: DRUG; Name: IR CD-LD; Assigned to Arm(s): IPX066, IR CD-LD
B: Arm Label: EXPERIMENTAL; Type: EXPERIMENTAL; Interventions: Behavioral: an 8-week blended indoor-outdoor exercise program | Arm Label: CONTROL; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: an 8-week upper limb and hand exercise program | Intervention Type: BEHAVIORAL; Name: an 8-week blended indoor-outdoor exercise program; Assigned to Arm(s): EXPERIMENTAL | Intervention Type: BEHAVIORAL; Name: an 8-week upper limb and hand exercise program; Assigned to Arm(s): CONTROL
C: Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Device: Gait Trainer 3 | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Device: Gait Trainer 3 | Intervention Type: DEVICE; Name: Gait Trainer 3; Assigned to Arm(s): Control Group, Experimental group
D: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Other: interactive video game-based exercise, Other: no intervention | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Other: interactive video game-based exercise, Other: no intervention | Intervention Type: OTHER; Name: interactive video game-based exercise; Assigned to Arm(s): Group A, Group B | Intervention Type: OTHER; Name: no intervention; Assigned to Arm(s): Group A, Group B

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Maintenance of Occupational Therapy for Patients With Alzheimer: A Pragmatic Randomized Trial
Brief Summary: France put a massive effort for improving dementia care through a national Alzheimer plan in 2008 and this effort was confirmed by the next government (Neurodegenerative Diseases Plan 2014-2019). Some new care models and interventions have been implemented such as Alzheimer specialized teams offering occupational therapy. The teams intervene at home with medical prescription. A recent pilot study demonstrated that occupational therapy has the potential to bring clinical benefits for both dementia patients and their caregivers. Nevertheless, occupational therapy has been designed as a short-term intervention and the end of intervention is challenging for therapists and patients. We aim to test the clinical and economic efficacy of maintaining occupational therapy over supplementary 4 months in a pragmatic randomized controlled trial.


Options:
A: Intervention Type: BEHAVIORAL; Name: Home-Based Behavorial Intervention; Assigned to Arm(s): N/A
B: Arm Label: intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: maintaining of occupational therapy | Arm Label: control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: maintaining of occupational therapy; Assigned to Arm(s): intervention arm
C: Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: COPE plus usual care; Type: EXPERIMENTAL; Interventions: Behavioral: Care of Persons with Dementia in their Environments | Intervention Type: BEHAVIORAL; Name: Care of Persons with Dementia in their Environments; Assigned to Arm(s): COPE plus usual care
D: Intervention Type: BEHAVIORAL; Name: community occupational therapy in dementia; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Piloting At-birth Point of Care HIV Testing Strategies in Kenya
Brief Summary: Innovative strategies to expedite HIV diagnosis among exposed infants, including at-birth testing and two portable point-of-care (POC) diagnostic systems, will be piloted using an implementation framework. The programmatic impact of these tools on early infant diagnosis (EID) will be measured in comparison with parallel standard of care (SOC) HIV DNA PCR testing initiated at 6 weeks of age.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Device: Alere q | Intervention Type: DEVICE; Name: Alere q; Assigned to Arm(s): Intervention
B: Arm Label: Primary Health care clinics; Type: N/A; Interventions: N/A | Arm Label: Pregnant and breast feeding women; Type: N/A; Interventions: N/A
C: Arm Label: In-vitro Diagnostics; Type: OTHER; Interventions: Other: In-vitro Diagnostics | Intervention Type: OTHER; Name: In-vitro Diagnostics; Assigned to Arm(s): In-vitro Diagnostics
D: Arm Label: Alere q HIV-1/2 Detect for point of care infant testing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Alere q HIV-1/2 Detect for point of care infant testing, Behavioral: HIV DNA PCR testing (Standard of Care) | Arm Label: GeneXpert HIV-1 Qual for point of care infant testing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: GeneXpert HIV-1 Qual for point of care infant testing, Behavioral: HIV DNA PCR testing (Standard of Care) | Intervention Type: BEHAVIORAL; Name: Alere q HIV-1/2 Detect for point of care infant testing; Assigned to Arm(s): Alere q HIV-1/2 Detect for point of care infant testing | Intervention Type: BEHAVIORAL; Name: GeneXpert HIV-1 Qual for point of care infant testing; Assigned to Arm(s): GeneXpert HIV-1 Qual for point of care infant testing | Intervention Type: BEHAVIORAL; Name: HIV DNA PCR testing (Standard of Care); Assigned to Arm(s): Alere q HIV-1/2 Detect for point of care infant testing, GeneXpert HIV-1 Qual for point of care infant testing

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Active School. A School-based Intervention to Increase Childrens Daily Physical Activity and Its Effect on Childrens Self-regulation
Brief Summary: This study seeks to explore whether increased physical activity in school affects children's executive function, aerobic Fitness and childrens self-regulation. The "Active school" study was a 10-month randomized controlled trial. The sample included 449 children (10-11 years old) in five intervention and four control schools. The weekly interventions were 2×45 minutes physically active academic lessons, 5×10 minutes physically active breaks, and 5×10 minutes physically active homework. Aerobic fitness was measured using a 10-minute interval running test. Executive function was tested using four cognitive tests (Stroop, verbal fluency, digit span, and Trail Making). A composite score for executive function was computed and used in analyses.

Self-regulation was measured by the Child Behavior Rating Scale.


Options:
A: Arm Label: Physical activity; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity | Intervention Type: BEHAVIORAL; Name: Physical activity; Assigned to Arm(s): Physical activity
B: Arm Label: Intervention group- Health-E-PALS; Type: EXPERIMENTAL; Interventions: Other: Health-E-PALS- | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Health-E-PALS-; Assigned to Arm(s): Intervention group- Health-E-PALS
C: Arm Label: Walking/Running Program; Type: EXPERIMENTAL; Interventions: Behavioral: Walking/Running program | Arm Label: Classroom activity break program; Type: EXPERIMENTAL; Interventions: Behavioral: Classroom physical activity break program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Walking/Running program; Assigned to Arm(s): Walking/Running Program | Intervention Type: BEHAVIORAL; Name: Classroom physical activity break program; Assigned to Arm(s): Classroom activity break program
D: Arm Label: PAAC-R; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity Across the Curriculum | Arm Label: PAAC-T; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity Across the Curriculum | Intervention Type: BEHAVIORAL; Name: Physical Activity Across the Curriculum; Assigned to Arm(s): PAAC-R, PAAC-T

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of Antibiotic Prophylaxis in Rectal Cancer Surgery: Oral With Intravenous Versus Intravenous Antibiotics.
Brief Summary: This is a randomized, controlled, parallel study to determine the efficiency of oral antibiotics in reduction of surgical site infection (SSI) in rectal cancer surgery.


Options:
A: Arm Label: Mechanical and oral antibiotic bowel preparation; Type: EXPERIMENTAL; Interventions: Drug: neomycin, metronidazole, polyethylene glycol (PEG) | Arm Label: No bowel preparation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: neomycin, metronidazole, polyethylene glycol (PEG); Assigned to Arm(s): Mechanical and oral antibiotic bowel preparation
B: Intervention Type: DRUG; Name: polyethylene glycol bowel lavage solution; Assigned to Arm(s): N/A
C: Arm Label: Arm I (mechanical bowel prep, oral antibiotics); Type: ACTIVE_COMPARATOR; Interventions: Drug: Polyethylene Glycol, Drug: Neomycin, Drug: Metronidazole Hydrochloride, Procedure: Therapeutic Conventional Surgery | Arm Label: Arm II (oral antibiotics); Type: EXPERIMENTAL; Interventions: Drug: Neomycin, Drug: Metronidazole Hydrochloride, Procedure: Therapeutic Conventional Surgery | Intervention Type: DRUG; Name: Polyethylene Glycol; Assigned to Arm(s): Arm I (mechanical bowel prep, oral antibiotics) | Intervention Type: DRUG; Name: Neomycin; Assigned to Arm(s): Arm I (mechanical bowel prep, oral antibiotics), Arm II (oral antibiotics) | Intervention Type: DRUG; Name: Metronidazole Hydrochloride; Assigned to Arm(s): Arm I (mechanical bowel prep, oral antibiotics), Arm II (oral antibiotics) | Intervention Type: PROCEDURE; Name: Therapeutic Conventional Surgery; Assigned to Arm(s): Arm I (mechanical bowel prep, oral antibiotics), Arm II (oral antibiotics)
D: Arm Label: Oral with Intravenous; Type: EXPERIMENTAL; Interventions: Drug: Oral antibiotic, Drug: Intravenous antibiotic, Drug: Mechanical Bowel Preparation | Arm Label: Intravenous; Type: ACTIVE_COMPARATOR; Interventions: Drug: Intravenous antibiotic, Drug: Mechanical Bowel Preparation | Intervention Type: DRUG; Name: Oral antibiotic; Assigned to Arm(s): Oral with Intravenous | Intervention Type: DRUG; Name: Intravenous antibiotic; Assigned to Arm(s): Intravenous, Oral with Intravenous | Intervention Type: DRUG; Name: Mechanical Bowel Preparation; Assigned to Arm(s): Intravenous, Oral with Intravenous

Answer: D